Pure Global

Open-Label Placebo for Non-Specific Pain in the ED - Trial NCT06408519

Access comprehensive clinical trial information for NCT06408519 through Pure Global AI's free database. This phase not specified trial is sponsored by Bruno Minotti and is currently Not yet recruiting. The study focuses on Pain, Acute. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06408519
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06408519
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Open-Label Placebo for Non-Specific Pain in the ED
Open -Label Placebo for Non-specific Pain in the Emergency Department: Study Protocol for a Mixed-method Randomised Control Feasibility Study

Study Focus

Pain, Acute

Placebo (open-label)

Interventional

other

Sponsor & Location

Bruno Minotti

University Hospital, Basel, Switzerland

Timeline & Enrollment

N/A

May 23, 2024

May 01, 2025

50 participants

Primary Outcome

Rate of eligible patients consenting to participate,Rate of patients adhering to the study protocol in terms of medication intake,Rate of patients completing their outcome (self-)assessments (i.e. questionnaires),Rate of patients' satisfaction with the intervention and study procedure

Summary

The aim of this study is to assess whether an intervention with open-label placebo (OLP) for
 non-specific pain in the emergency department is feasible.

ICD-10 Classifications

Acute pain
Pain, unspecified
Pain, not elsewhere classified
Acute abdomen
Acute myringitis

Data Source

ClinicalTrials.gov

NCT06408519

Non-Device Trial